ID   MYH9_RAT                Reviewed;        1961 AA.
AC   Q62812;
DT   27-APR-2001, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   02-OCT-2024, entry version 180.
DE   RecName: Full=Myosin-9;
DE   AltName: Full=Cellular myosin heavy chain, type A;
DE   AltName: Full=Myosin heavy chain 9;
DE   AltName: Full=Myosin heavy chain, non-muscle IIa;
DE   AltName: Full=Non-muscle myosin heavy chain A;
DE            Short=NMMHC-A;
DE   AltName: Full=Non-muscle myosin heavy chain IIa;
DE            Short=NMMHC II-a;
DE            Short=NMMHC-IIA;
GN   Name=Myh9;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=8740433; DOI=10.1007/bf00140325;
RA   Choi O.H., Park C., Itoh K., Adelstein R.S., Beaven M.A.;
RT   "Cloning of the cDNA encoding rat myosin heavy chain-A and evidence for the
RT   absence of myosin heavy chain-B in cultured rat mast (RBL-2H3) cells.";
RL   J. Muscle Res. Cell Motil. 17:69-77(1996).
RN   [2]
RP   PROTEIN SEQUENCE OF 181-199; 546-555; 618-639; 1241-1248; 1402-1411;
RP   1446-1455; 1474-1478; 1557-1567; 1605-1614; 1793-1803 AND 1925-1934, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RA   Lubec G., Kang S.U., Lubec S.;
RL   Submitted (SEP-2007) to UniProtKB.
RN   [3]
RP   RETRACTED PAPER.
RX   PubMed=12944413; DOI=10.1074/jbc.m306360200;
RA   Ozaslan D., Wang S., Ahmed B.A., Kocabas A.M., McCastlain J.C., Bene A.,
RA   Kilic F.;
RT   "Glycosyl modification facilitates homo- and hetero-oligomerization of the
RT   serotonin transporter. A specific role for sialic acid residues.";
RL   J. Biol. Chem. 278:43991-44000(2003).
RN   [4]
RP   RETRACTION NOTICE OF PUBMED:12944413.
RX   PubMed=31201245; DOI=10.1074/jbc.w119.009466;
RA   Ozaslan D., Wang S., Ahmed B.A., Kocabas A.M., McCastlain J.C., Bene A.,
RA   Kilic F.;
RT   "Withdrawal: Glycosyl modification facilitates homo- and hetero-
RT   oligomerization of the serotonin transporter: a specific role for sialic
RT   acid residues.";
RL   J. Biol. Chem. 294:9657-9657(2019).
RN   [5]
RP   INTERACTION WITH PDLIM2.
RX   PubMed=15505042; DOI=10.1167/iovs.04-0721;
RA   Torrado M., Senatorov V.V., Trivedi R., Fariss R.N., Tomarev S.I.;
RT   "Pdlim2, a novel PDZ-LIM domain protein, interacts with alpha-actinins and
RT   filamin A.";
RL   Invest. Ophthalmol. Vis. Sci. 45:3955-3963(2004).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-754; SER-1114; SER-1715 AND
RP   SER-1944, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Cellular myosin that appears to play a role in cytokinesis,
CC       cell shape, and specialized functions such as secretion and capping (By
CC       similarity). Required for cortical actin clearance prior to oocyte
CC       exocytosis (By similarity). Promotes cell motility in conjunction with
CC       S100A4 (By similarity). During cell spreading, plays an important role
CC       in cytoskeleton reorganization, focal contact formation (in the margins
CC       but not the central part of spreading cells), and lamellipodial
CC       retraction; this function is mechanically antagonized by MYH10 (By
CC       similarity). {ECO:0000250|UniProtKB:P35579,
CC       ECO:0000250|UniProtKB:Q8VDD5}.
CC   -!- SUBUNIT: Myosin is a hexameric protein that consists of 2 heavy chain
CC       subunits (MHC), 2 alkali light chain subunits (MLC) and 2 regulatory
CC       light chain subunits (MLC-2). Interacts with RASIP1 (By similarity).
CC       Interacts with DDR1 (By similarity). Interacts with PDLIM2
CC       (PubMed:15505042). Interacts with SVIL (By similarity). Interacts with
CC       HTRA3 (By similarity). Interacts with Myo7a (By similarity). Interacts
CC       with CFAP95 (By similarity). Interacts with LIMCH1; independently of
CC       the integration of MYH9 into the myosin complex (By similarity).
CC       Interacts with RAB3A (By similarity). Interacts with ZBED4 (By
CC       similarity). Interacts with S100A4; this interaction increases cell
CC       motility (By similarity). {ECO:0000250|UniProtKB:P35579,
CC       ECO:0000250|UniProtKB:Q8VDD5, ECO:0000269|PubMed:15505042}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton
CC       {ECO:0000250|UniProtKB:Q8VDD5}. Cytoplasm, cell cortex
CC       {ECO:0000250|UniProtKB:Q8VDD5}. Cytoplasmic vesicle, secretory vesicle,
CC       Cortical granule {ECO:0000250|UniProtKB:Q8VDD5}. Note=Colocalizes with
CC       actin filaments at lamellipodia margins and at the leading edge of
CC       migrating cells (By similarity). In retinal pigment epithelial cells,
CC       predominantly localized to stress fiber-like structures with some
CC       localization to cytoplasmic puncta (By similarity).
CC       {ECO:0000250|UniProtKB:P35579}.
CC   -!- DOMAIN: The rodlike tail sequence is highly repetitive, showing cycles
CC       of a 28-residue repeat pattern composed of 4 heptapeptides,
CC       characteristic for alpha-helical coiled coils.
CC   -!- PTM: ISGylated. {ECO:0000250|UniProtKB:P35579,
CC       ECO:0000250|UniProtKB:Q8VDD5}.
CC   -!- PTM: Ubiquitination. {ECO:0000250|UniProtKB:P35579,
CC       ECO:0000250|UniProtKB:Q8VDD5}.
CC   -!- SIMILARITY: Belongs to the TRAFAC class myosin-kinesin ATPase
CC       superfamily. Myosin family. {ECO:0000305}.
CC   -!- CAUTION: Reported to interact with SLC6A4 in its sialylated form.
CC       However, this publication was retracted due to image duplication in the
CC       figures. {ECO:0000305|PubMed:12944413, ECO:0000305|PubMed:31201245}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U31463; AAA74950.1; -; mRNA.
DR   AlphaFoldDB; Q62812; -.
DR   SMR; Q62812; -.
DR   BioGRID; 247773; 10.
DR   CORUM; Q62812; -.
DR   IntAct; Q62812; 5.
DR   MINT; Q62812; -.
DR   STRING; 10116.ENSRNOP00000007398; -.
DR   CarbonylDB; Q62812; -.
DR   GlyGen; Q62812; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q62812; -.
DR   PhosphoSitePlus; Q62812; -.
DR   SwissPalm; Q62812; -.
DR   jPOST; Q62812; -.
DR   PaxDb; 10116-ENSRNOP00000007398; -.
DR   UCSC; RGD:3140; rat.
DR   AGR; RGD:3140; -.
DR   RGD; 3140; Myh9.
DR   eggNOG; KOG0161; Eukaryota.
DR   InParanoid; Q62812; -.
DR   PhylomeDB; Q62812; -.
DR   Reactome; R-RNO-2029482; Regulation of actin dynamics for phagocytic cup formation.
DR   Reactome; R-RNO-5627123; RHO GTPases activate PAKs.
DR   PRO; PR:Q62812; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0015629; C:actin cytoskeleton; ISS:UniProtKB.
DR   GO; GO:0005884; C:actin filament; IDA:RGD.
DR   GO; GO:0042641; C:actomyosin; ISO:RGD.
DR   GO; GO:0005826; C:actomyosin contractile ring; ISS:UniProtKB.
DR   GO; GO:0005912; C:adherens junction; ISO:RGD.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:RGD.
DR   GO; GO:0005903; C:brush border; IDA:RGD.
DR   GO; GO:0005938; C:cell cortex; ISS:UniProtKB.
DR   GO; GO:0031252; C:cell leading edge; ISS:UniProtKB.
DR   GO; GO:0032154; C:cleavage furrow; ISS:UniProtKB.
DR   GO; GO:0008180; C:COP9 signalosome; ISO:RGD.
DR   GO; GO:0030863; C:cortical cytoskeleton; ISO:RGD.
DR   GO; GO:0060473; C:cortical granule; ISS:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0009898; C:cytoplasmic side of plasma membrane; ISO:RGD.
DR   GO; GO:0005829; C:cytosol; ISS:UniProtKB.
DR   GO; GO:0005768; C:endosome; IDA:RGD.
DR   GO; GO:0005925; C:focal adhesion; ISO:RGD.
DR   GO; GO:0001772; C:immunological synapse; ISO:RGD.
DR   GO; GO:0030027; C:lamellipodium; IDA:RGD.
DR   GO; GO:0016328; C:lateral plasma membrane; IDA:RGD.
DR   GO; GO:0016459; C:myosin complex; ISO:RGD.
DR   GO; GO:0032982; C:myosin filament; IBA:GO_Central.
DR   GO; GO:0016460; C:myosin II complex; ISO:RGD.
DR   GO; GO:0097513; C:myosin II filament; ISO:RGD.
DR   GO; GO:0031594; C:neuromuscular junction; ISO:RGD.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0045335; C:phagocytic vesicle; IDA:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0032991; C:protein-containing complex; IDA:RGD.
DR   GO; GO:0001726; C:ruffle; ISS:UniProtKB.
DR   GO; GO:0005819; C:spindle; ISO:RGD.
DR   GO; GO:0001725; C:stress fiber; ISS:UniProtKB.
DR   GO; GO:0001931; C:uropod; ISO:RGD.
DR   GO; GO:0003779; F:actin binding; ISO:RGD.
DR   GO; GO:0051015; F:actin filament binding; ISS:UniProtKB.
DR   GO; GO:0043531; F:ADP binding; ISO:RGD.
DR   GO; GO:0005524; F:ATP binding; ISO:RGD.
DR   GO; GO:0005516; F:calmodulin binding; IEA:UniProtKB-KW.
DR   GO; GO:0031762; F:follicle-stimulating hormone receptor binding; IDA:RGD.
DR   GO; GO:0001965; F:G-protein alpha-subunit binding; IDA:RGD.
DR   GO; GO:0042802; F:identical protein binding; IDA:RGD.
DR   GO; GO:0005178; F:integrin binding; ISS:UniProtKB.
DR   GO; GO:0000146; F:microfilament motor activity; ISS:UniProtKB.
DR   GO; GO:0005391; F:P-type sodium:potassium-exchanging transporter activity; ISS:UniProtKB.
DR   GO; GO:0019904; F:protein domain specific binding; ISO:RGD.
DR   GO; GO:0042803; F:protein homodimerization activity; ISS:UniProtKB.
DR   GO; GO:0019901; F:protein kinase binding; IPI:RGD.
DR   GO; GO:0043495; F:protein-membrane adaptor activity; ISS:UniProtKB.
DR   GO; GO:0097110; F:scaffold protein binding; IDA:RGD.
DR   GO; GO:0030036; P:actin cytoskeleton organization; ISS:UniProtKB.
DR   GO; GO:0051017; P:actin filament bundle assembly; IMP:RGD.
DR   GO; GO:0070650; P:actin filament bundle distribution; IMP:RGD.
DR   GO; GO:0030048; P:actin filament-based movement; ISS:UniProtKB.
DR   GO; GO:0031032; P:actomyosin structure organization; ISO:RGD.
DR   GO; GO:0001525; P:angiogenesis; ISS:UniProtKB.
DR   GO; GO:0043534; P:blood vessel endothelial cell migration; ISS:UniProtKB.
DR   GO; GO:0007155; P:cell adhesion; ISO:RGD.
DR   GO; GO:0000902; P:cell morphogenesis; ISO:RGD.
DR   GO; GO:0048870; P:cell motility; ISO:RGD.
DR   GO; GO:0098609; P:cell-cell adhesion; IMP:RGD.
DR   GO; GO:0071260; P:cellular response to mechanical stimulus; IEP:RGD.
DR   GO; GO:0036120; P:cellular response to platelet-derived growth factor stimulus; IEP:RGD.
DR   GO; GO:0060471; P:cortical granule exocytosis; ISS:UniProtKB.
DR   GO; GO:0032506; P:cytokinetic process; ISS:UniProtKB.
DR   GO; GO:0035987; P:endodermal cell differentiation; ISO:RGD.
DR   GO; GO:0051295; P:establishment of meiotic spindle localization; ISO:RGD.
DR   GO; GO:0001768; P:establishment of T cell polarity; ISO:RGD.
DR   GO; GO:0042699; P:follicle-stimulating hormone signaling pathway; IMP:RGD.
DR   GO; GO:0001701; P:in utero embryonic development; ISO:RGD.
DR   GO; GO:0032418; P:lysosome localization; ISO:RGD.
DR   GO; GO:0000212; P:meiotic spindle organization; ISO:RGD.
DR   GO; GO:0006509; P:membrane protein ectodomain proteolysis; ISS:UniProtKB.
DR   GO; GO:0030224; P:monocyte differentiation; ISS:UniProtKB.
DR   GO; GO:0007520; P:myoblast fusion; ISO:RGD.
DR   GO; GO:1903919; P:negative regulation of actin filament severing; ISO:RGD.
DR   GO; GO:1904753; P:negative regulation of vascular associated smooth muscle cell migration; IMP:RGD.
DR   GO; GO:0006911; P:phagocytosis, engulfment; ISO:RGD.
DR   GO; GO:0007200; P:phospholipase C-activating G protein-coupled receptor signaling pathway; IMP:RGD.
DR   GO; GO:0001778; P:plasma membrane repair; ISO:RGD.
DR   GO; GO:0030220; P:platelet formation; ISS:UniProtKB.
DR   GO; GO:0045807; P:positive regulation of endocytosis; IMP:RGD.
DR   GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IMP:RGD.
DR   GO; GO:0051894; P:positive regulation of focal adhesion assembly; IMP:RGD.
DR   GO; GO:0045745; P:positive regulation of G protein-coupled receptor signaling pathway; IMP:RGD.
DR   GO; GO:0032962; P:positive regulation of inositol trisphosphate biosynthetic process; IMP:RGD.
DR   GO; GO:0035774; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; IMP:RGD.
DR   GO; GO:0050766; P:positive regulation of phagocytosis; IMP:RGD.
DR   GO; GO:1903923; P:positive regulation of protein processing in phagocytic vesicle; ISO:RGD.
DR   GO; GO:0015031; P:protein transport; ISS:UniProtKB.
DR   GO; GO:0045055; P:regulated exocytosis; ISO:RGD.
DR   GO; GO:0110053; P:regulation of actin filament organization; IMP:RGD.
DR   GO; GO:0008360; P:regulation of cell shape; ISS:UniProtKB.
DR   GO; GO:1905684; P:regulation of plasma membrane repair; ISO:RGD.
DR   GO; GO:0032796; P:uropod organization; ISO:RGD.
DR   Gene3D; 1.10.10.820; -; 1.
DR   Gene3D; 1.20.5.340; -; 6.
DR   Gene3D; 1.20.58.530; -; 1.
DR   Gene3D; 3.30.70.1590; -; 1.
DR   Gene3D; 6.10.250.2420; -; 1.
DR   Gene3D; 3.40.850.10; Kinesin motor domain; 1.
DR   Gene3D; 2.30.30.360; Myosin S1 fragment, N-terminal; 1.
DR   Gene3D; 1.20.120.720; Myosin VI head, motor domain, U50 subdomain; 1.
DR   Gene3D; 4.10.270.10; Myosin, subunit A; 1.
DR   InterPro; IPR000048; IQ_motif_EF-hand-BS.
DR   InterPro; IPR036961; Kinesin_motor_dom_sf.
DR   InterPro; IPR001609; Myosin_head_motor_dom.
DR   InterPro; IPR004009; Myosin_N.
DR   InterPro; IPR008989; Myosin_S1_N.
DR   InterPro; IPR002928; Myosin_tail.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   PANTHER; PTHR45615; MYOSIN HEAVY CHAIN, NON-MUSCLE; 1.
DR   PANTHER; PTHR45615:SF16; MYOSIN-9; 1.
DR   Pfam; PF00063; Myosin_head; 1.
DR   Pfam; PF02736; Myosin_N; 1.
DR   Pfam; PF01576; Myosin_tail_1; 1.
DR   PRINTS; PR00193; MYOSINHEAVY.
DR   SMART; SM00015; IQ; 1.
DR   SMART; SM00242; MYSc; 1.
DR   SUPFAM; SSF90257; Myosin rod fragments; 6.
DR   SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 1.
DR   SUPFAM; SSF57997; Tropomyosin; 1.
DR   PROSITE; PS50096; IQ; 1.
DR   PROSITE; PS51456; MYOSIN_MOTOR; 1.
DR   PROSITE; PS51844; SH3_LIKE; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Actin-binding; ATP-binding; Calmodulin-binding; Cell adhesion;
KW   Cell shape; Coiled coil; Cytoplasm; Cytoplasmic vesicle; Cytoskeleton;
KW   Direct protein sequencing; Methylation; Motor protein; Myosin;
KW   Nucleotide-binding; Phosphoprotein; Reference proteome; Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:P35579"
FT   CHAIN           2..1961
FT                   /note="Myosin-9"
FT                   /id="PRO_0000123418"
FT   DOMAIN          27..77
FT                   /note="Myosin N-terminal SH3-like"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01190"
FT   DOMAIN          81..776
FT                   /note="Myosin motor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00782"
FT   DOMAIN          779..808
FT                   /note="IQ"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00116"
FT   REGION          2..838
FT                   /note="Mediates interaction with LIMCH1"
FT                   /evidence="ECO:0000250|UniProtKB:P35579"
FT   REGION          654..676
FT                   /note="Actin-binding"
FT   REGION          1035..1057
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1331..1353
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1878..1910
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1938..1961
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          841..1927
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        1878..1909
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         174..181
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000250|UniProtKB:P35579"
FT   MOD_RES         8
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P35579"
FT   MOD_RES         11
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P35579"
FT   MOD_RES         102
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P35579"
FT   MOD_RES         299
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P35579"
FT   MOD_RES         435
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P35580"
FT   MOD_RES         613
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VDD5"
FT   MOD_RES         628
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P35579"
FT   MOD_RES         754
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         850
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VDD5"
FT   MOD_RES         860
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VDD5"
FT   MOD_RES         975
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VDD5"
FT   MOD_RES         1024
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P35579"
FT   MOD_RES         1114
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         1234
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q61879"
FT   MOD_RES         1249
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VDD5"
FT   MOD_RES         1358
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P35579"
FT   MOD_RES         1393
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P35579"
FT   MOD_RES         1405
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P35579"
FT   MOD_RES         1411
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P35579"
FT   MOD_RES         1460
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P35579"
FT   MOD_RES         1639
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P35579"
FT   MOD_RES         1670
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VDD5"
FT   MOD_RES         1715
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         1794
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VDD5"
FT   MOD_RES         1803
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VDD5"
FT   MOD_RES         1846
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VDD5"
FT   MOD_RES         1924
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q61879"
FT   MOD_RES         1944
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
SQ   SEQUENCE   1961 AA;  226338 MW;  9B9876D9681FB19E CRC64;
     MAQQAADKYL YVDKNFINNP LAQADCGAKK LVWVPSTKNG FEPASLKEEV GEEAIVELVE
     NGKKVKVNKD DIQKMNPPKF SKVEDMAELT CLNEASVLHN LKERYYSGLI YTYSGLFCVV
     INPYKNLPIY SEEIVDMYKG KKRHEMPPHI YAITDTAYRS MMQDREDQSI LCTGESGAGK
     TENTKKVIQY LAHVASSHKS KKDQGELERQ LLQANPILEA FGNAKTVKND NSSRFGKFIR
     INFDVNGYIV GANIETYLLE KSRAIRQAKE ERTFHIFYYL LSGAGEHLKT DLLLEPYNKY
     RFLSNGHVTI PGQQDKDMFQ ETMEAMRIMG IPEDEQMGLL RVISGVLQLG NIVFKKERNT
     DQASMPDNTA AQKVSHLLGI NVTDFTRGIL TPRIKVGRDY VQKAQTKEQA DFAIEALAKA
     TYERMFRWLV LRINKALDKT KRQGASFIGI LDIAGFEIFD LNSFEQLCIN YTNEKLQQLF
     NHTMFILEQE EYQREGIEWN FIDFGLDLQP CIDLIEKPAG PPGILALLDE ECWFPKATDK
     SFVEKVVQEQ GTHPKFQKPK QLKDKADFCI IHYAGKVDYK ADEWLMKNMD PLNDNIATLL
     HQSSDKFVSE LWKDVDRIIG LDQVAGMSET ALPGAFKTRK GMFRTVGQLY KEQLAKLMAT
     LRNTNPNFVC CIIPNHEKKA GKLDPHLVLD QLRCNGVLEG IRICRQGFPN RVVFQEFRQR
     YEILTPNSIP KGFMDGKQAC VLMIKALELD SNLYRIGQSK VFFRSGVLAH LEEERDLKIT
     DVIIGFQACC RGYLARKAFA KRQQQLTAMK VLQRNCAAYL RLRNWQWWRL FTKVKPLLNS
     IRHEDELLAK EAELTKVREK HLAAENRLTE METMQSQLMA EKLQLQEQLQ AKTELCAEAE
     ELRARLTAKK QELEEICHDL EARVEEEEER CQYLQAEKKK MQQNIQELEE QLEEEESARQ
     KLQLEKVTTE AKLKKLEEDQ IIMEDQNCKL AKEKKLLEDR VAEFTTDLME EEEKSKSLAK
     LKNKHEAMIT DLEERLRREE KQRQELEKTR RKLEGDSTDL SDQIAELQAQ IAELKMQLAK
     KEEELQAALA RVEEEAAQKN MALKKIRELE TQISELQEDL ESERACRNKA EKQKRDLGEE
     LEALKTELED TLDSTAAQQE LRSKREQEVS ILKKTLEDEA KTHEAQIQEM RQKHSQAVEE
     LAEQLEQTKR VKATLEKAKQ TLENERGELA NEVKALLQGK GDSEHKRKKV EAQLQELQVK
     FSEGERVRTE LADKVSKLQV ELDSVTGLLN QSDSKSSKLT KDFSALESQL QDTQELLQEE
     NRQKLSLSTK LKQMEDEKNS FREQLEEEEE EAKRNLEKQI ATLHAQVTDM KKKMEDGVGC
     LETAEEAKRR LQKDLEGLSQ RLEEKVAAYD KLEKTKTRLQ QELDDLLVDL DHQRQSVSNL
     EKKQKKFDQL LAEEKTISAK YAEERDRAEA EAREKETKAL SLARALEEAM EQKAELERLN
     KQFRTEMEDL MSSKDDVGKS VHELEKSNRA LEQQVEEMKT QLEELEDELQ ATEDAKLRLE
     VNLQAMKAQF ERDLQGRDEQ SEEKKKQLVR QVREMEAELE DERKQRSIAM AARKKLEMDL
     KDLEAHIDTA NKNREEAIKQ LRKLQAQMKD CMRDVDDTRA SREEILAQAK ENEKKLKSME
     AEMIQLQEEL AAAERAKRQA QQERDELADE IANSSGKGAL ALEEKRRLEA LIALLEEELE
     EEQGNTELIN DRLKKANLQI DQINTDLNLE RSHAQKNENA RQQLERQNKE LKAKLQEMES
     AVKSKYKASI AALEAKIAQL EEQLDNETKE RQAASKQVRR AEKKLKDVLL QVEDERRNAE
     QFKDQADKAS TRLKQLKRQL EEAEEEAQRA NASRRKLQRE LEDATETADA MNREVSSLKN
     KLRRGDMPFV VTRRIVRKGT GDCSDEEVDG KADGADAKAT E
//
